These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6150096)

  • 1. Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasma.
    Chen DS; Nussberger J; Brunner HR; Waeber B
    J Pharm Pharmacol; 1984 Oct; 36(10):707-8. PubMed ID: 6150096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.
    Snyder RA; Wintroub BU
    Biochim Biophys Acta; 1986 May; 871(1):1-5. PubMed ID: 3008847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML; Kurz KD; Schenck KW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of pentopril, a new angiotensin-converting-enzyme inhibitor in humans.
    Rakhit A; Hurley ME; Tipnis V; Coleman J; Rommel A; Brunner HR
    J Clin Pharmacol; 1986 Mar; 26(3):156-64. PubMed ID: 3007583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
    Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ
    J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.
    Krebs LT; Hanesworth JM; Sardinia MF; Speth RC; Wright JW; Harding JW
    J Pharmacol Exp Ther; 2000 Apr; 293(1):260-7. PubMed ID: 10734177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme.
    Patchett AA; Cordes EH
    Adv Enzymol Relat Areas Mol Biol; 1985; 57():1-84. PubMed ID: 2994404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent kinetics of angiotensin converting enzyme: hydrolysis of [3H]benzoyl-phenylalanyl-alanyl-proline in the isolated perfused lung.
    Ashton JH; Pitt BR; Gillis CN
    J Pharmacol Exp Ther; 1985 Mar; 232(3):602-7. PubMed ID: 2983065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rabbit lung angiotensin converting enzyme by idrapril.
    Lippi A; Criscuoli M; Sardelli G; Subissi A
    Biochem Pharmacol; 1993 Mar; 45(6):1358-62. PubMed ID: 8385462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
    Perich RB; Jackson B; Johnston CI
    Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition.
    Nishiyama A; Seth DM; Navar LG
    J Am Soc Nephrol; 2002 Sep; 13(9):2207-12. PubMed ID: 12191964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.
    Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.